Javascript must be enabled to continue!
Misleading arrows? Fitness landscapes and cancer progression models
View through CrossRef
Abstract
Cancer progression models such as Oncogenetic Tress [1], Conjunctive Bayesian Networks [2], or CAPRI [3], try to infer possible restrictions in the order of accumulation of mutations using cancer cross-sectional data. These restrictions would arise from epistatic interactions between mutations. The Directed Acyclic Graphs (DAGs) returned by these methods predict the genotypes that can and cannot be observed. Since fitness landscapes are shaped by those same epistatics interactions and also specify what genotypes are accessible and inaccessible [4] we would expect a close correspondence between a fitness landscape and the DAGs inferred from evolutionary processes in that landscape. I will show here, however, that there is a many-to- many mapping between fitness landscapes and DAGs inferred from cancer progression models. I show that many fitness landscapes cannot be represented by a cancer progression DAG in the sense that no DAG can codify the genotypes that are accessible under that landscape and I propose two measures of “DAG-non-representability”. Next, using 500 different random fitness lanscapes (with 100 begin perfectly DAG-representable) I simulate cancer progression using different mutation rates and sampling regimes; I analyze 20 replicates (of 1000 genotypes) under each condition with CAPRI[3] and CBN[2]. I show that, even under constant mutation and sampling regime conditions, data obtained from the same landscape lead to inferring widely different DAGs (e.g., median Gini-Simpson index of 0.5); this one-landscape-to-many-DAGs phenomenon increases with DAG-non-representability. I also show the one-DAG-to-many-landscapes phenomenon where the same DAG is frequently inferred from very different fitness landscapes (e.g., > 50% difference in accessible genotypes). Finally, I “reverse landscape engineer” the pancreatic cancer data used in [6]: using 190 random fitness landscapes, I show that genotype frequencies similar to the empirically observed one can be obtained under fitness landscapes that are very different from each other and that produce data that lead to the inference of DAGs that are also widely different among themselves (e.g., pairwise difference in edges of DAGs > 50%). I discuss the implications of these results for the interpretation and applied use of cancer progression models.
Novelty and significance
This paper explicitly establishes a connection between the inference of cancer progression models and the fitness landscapes that condition that cancer progression. It shows there is a many-to- many mapping between them, even under large sample sizes, that can limit their interpretability.
References
[1]R. Desper, et al., J Comput Biol 6, 37 (1999).
[2]M. Gerstung, M. Baudis, H. Moch, N. Beerenwinkel, Bioinformatics 25, 2809 (2009).
[3]G. Caravagna, et al., PNAS 113 E4025-E4034 (2016).
[4]J. Franke, A. Klözer, J. A. G. M. de Visser, J. Krug, PLoS Comput Biol 7, e1002134 (2011).
[5]K. Crona, D. Greene, M. Barlow, Journal of Theoretical Biology 317, 1 (2013).
[6]M. Gerstung, N. Eriksson, J. Lin, B. Vogelstein, N. Beerenwinkel, PLoS ONE 6, e27136 (2011).
Title: Misleading arrows? Fitness landscapes and cancer progression models
Description:
Abstract
Cancer progression models such as Oncogenetic Tress [1], Conjunctive Bayesian Networks [2], or CAPRI [3], try to infer possible restrictions in the order of accumulation of mutations using cancer cross-sectional data.
These restrictions would arise from epistatic interactions between mutations.
The Directed Acyclic Graphs (DAGs) returned by these methods predict the genotypes that can and cannot be observed.
Since fitness landscapes are shaped by those same epistatics interactions and also specify what genotypes are accessible and inaccessible [4] we would expect a close correspondence between a fitness landscape and the DAGs inferred from evolutionary processes in that landscape.
I will show here, however, that there is a many-to- many mapping between fitness landscapes and DAGs inferred from cancer progression models.
I show that many fitness landscapes cannot be represented by a cancer progression DAG in the sense that no DAG can codify the genotypes that are accessible under that landscape and I propose two measures of “DAG-non-representability”.
Next, using 500 different random fitness lanscapes (with 100 begin perfectly DAG-representable) I simulate cancer progression using different mutation rates and sampling regimes; I analyze 20 replicates (of 1000 genotypes) under each condition with CAPRI[3] and CBN[2].
I show that, even under constant mutation and sampling regime conditions, data obtained from the same landscape lead to inferring widely different DAGs (e.
g.
, median Gini-Simpson index of 0.
5); this one-landscape-to-many-DAGs phenomenon increases with DAG-non-representability.
I also show the one-DAG-to-many-landscapes phenomenon where the same DAG is frequently inferred from very different fitness landscapes (e.
g.
, > 50% difference in accessible genotypes).
Finally, I “reverse landscape engineer” the pancreatic cancer data used in [6]: using 190 random fitness landscapes, I show that genotype frequencies similar to the empirically observed one can be obtained under fitness landscapes that are very different from each other and that produce data that lead to the inference of DAGs that are also widely different among themselves (e.
g.
, pairwise difference in edges of DAGs > 50%).
I discuss the implications of these results for the interpretation and applied use of cancer progression models.
Novelty and significance
This paper explicitly establishes a connection between the inference of cancer progression models and the fitness landscapes that condition that cancer progression.
It shows there is a many-to- many mapping between them, even under large sample sizes, that can limit their interpretability.
References
[1]R.
Desper, et al.
, J Comput Biol 6, 37 (1999).
[2]M.
Gerstung, M.
Baudis, H.
Moch, N.
Beerenwinkel, Bioinformatics 25, 2809 (2009).
[3]G.
Caravagna, et al.
, PNAS 113 E4025-E4034 (2016).
[4]J.
Franke, A.
Klözer, J.
A.
G.
M.
de Visser, J.
Krug, PLoS Comput Biol 7, e1002134 (2011).
[5]K.
Crona, D.
Greene, M.
Barlow, Journal of Theoretical Biology 317, 1 (2013).
[6]M.
Gerstung, N.
Eriksson, J.
Lin, B.
Vogelstein, N.
Beerenwinkel, PLoS ONE 6, e27136 (2011).
Related Results
Developing Total Force Fitness and Its Components to Achieve Optimal Military Performance in Iran
Developing Total Force Fitness and Its Components to Achieve Optimal Military Performance in Iran
Abstract
Background Military personnel is the most valuable asset of the armed forces to carry out missions. The Iranian Armed Forces have not provided a comprehensive defi...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Purpose:
To make a diagnosis of cancer with BDORT (resonance test), we can choose two methods. One is to use a chemical agent like Integrin α5β1 or Oncogene C-f...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
A family of fitness landscapes modeled through gene regulatory networks
A family of fitness landscapes modeled through gene regulatory networks
AbstractOver 100 years, Fitness landscapes have been a powerful metaphor for understanding the evolution of biological systems. These landscapes describe how genotypes are connecte...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract
Introduction
Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
Abstract OI-1: OI-1 Decoding breast cancer predisposition genes
Abstract OI-1: OI-1 Decoding breast cancer predisposition genes
Abstract
Women with one or more first-degree female relatives with a history of breast cancer have a two-fold increased risk of developing breast cancer. This risk i...
Evolution in alternating environments with tunable inter-landscape correlations
Evolution in alternating environments with tunable inter-landscape correlations
Abstract
Natural populations are often exposed to temporally varying environments. Evolutionary dynamics in varying environments have been extensively studied, thou...

